NCT00402038View on ClinicalTrials.gov

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Advance Illness Patients With OIC
Interventions
DRUG

SC Methylnaltrexone

Dose 1

DRUG

SC Placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00402038 - Study of Methylnaltrexone (MNTX) for the Relief of Constipation | Biotech Hunter | Biotech Hunter